Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

His lifesaving melanoma research in Australia illuminated the treatment he underwent for his own brain tumor, an ordeal he ...

Pfizer (PFE) stock is in focus as the antibody-drug conjugate sigvotatug vedotin fails in a Phase 3 trial versus chemotherapy ...

Real-world data reveal racial disparities in cancer pain medication timing and strong opioid prescribing, with gaps most pronounced in breast and prostate cancer. Patients from racially and ethnically ...

A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively. By ...

Many patients with metastatic castration-resistant prostate cancer are not receiving bone-modifying agents, despite guideline endorsement.

Cancer immunotherapy has transformed the landscape of oncology by mobilizing the host immune system to recognize and eradicate malignant cells. Therapeutic ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...

Therapeutic radiopharmaceuticals have moved from niche applications to an increasingly important component of modern oncology. Agents such as ...

The IDF confirmed on Wednesday that it struck in the central Gaza Strip on Tuesday and eliminated the terrorist Ahmad Abu Hin, a Hamas military wing sniper cell commander, and Mahmoud Walid Jabr Abu ...

The government is to apologise to victims of historical forced adoptions in England, Education Secretary Bridget Phillipson has said, following years of campaigning from mothers and adoptees. An ...